SHS Capital Invests €18M in MESI Medical

June 22, 2023

Tübingen-based healthcare investor SHS (SHS Gesellschaft für Beteiligungsmanagement mbH) has invested €18 million in MESI, a Slovenian medtech company that develops the MESI mTABLET digital diagnostic platform. The growth capital will be used to expand MESI’s sales organization and product portfolio — including AI-powered predictive applications — to accelerate adoption across primary care, assisted care and other healthcare settings.

Targets
MESI Medical
Industry
Medical Devices
Location
Slovenia
Transaction Type
Growth capital

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.